Volcon Rebrands to Empery Digital, Launches $500M Bitcoin Treasury Strategy
By Daniella Parra Volcon (NASDAQ: VLCN) said it closed a $500 million private placement and...
Editorial
ReAlta Drug Shows Promise in Protecting Newborn Brains from Oxygen Deprivation Injuries
By Daniella Parra ReAlta Life Sciences said Pegtarazimod is being evaluated in a Phase 2...
Harry Upcott Joins Vinson & Elkins to Drive Aviation Finance Expansion in Europe
By Daniella Parra Vinson & Elkins has expanded its global aviation finance practice with the...
Lisata Secures New Composition of Matter Patent for Certepetide
By Daniella Parra Lisata Therapeutics said it has been granted a new composition of...
GameSquare ETH Strategy Quickens With $70 Million Offering
By Exec Edge Editorial Staff GameSquare Holdings (NASDAQ: GAME) said it completed a $70 million...
Going Public Alongside Veteran Dealmaker Daniel Hennessy with HVII – Initiation Report
Download the Complete Report Here By Rayk Riechmann With 12 successful SPAC transactions representing over...
Profit from the Wealth Management Revolution with Binah Capital Group – Exec Edge Research Initiation Report
Download the Complete Report Here The wealth management world is undergoing a revolution. One likely...
Inventiva Strengthens Leadership Team Ahead of Key MASH Drug Milestones
By Daniella Parra Inventiva said Dr. Jason Campagna has been named President of R&D and...
Ascentage Pharma Announces NMPA Approval for Blood Cancer Drug
By Karen Roman Ascentage Pharma Group International (Nasdaq: AAPG) said China’s National Medical Products Administration...
Deborah Geraghty Named President & CEO of Radiant Biotherapeutics
By Karen Roman Toronto-based biotech company Radiant Biotherapeutics announced the designation of Deborah Geraghty, Ph.D.,...
© Copyright 2025, ExecEdge